Pharma Journalist -

Sarah Cannon Research Institute and South Texas Research Accelerated Therapeutics moved to collaborate ensuring augmenting their globally acclaimed phase I drug development programs…
Read More...

Ipsen and Exelixis declared results of Phase 3 CELESTIAL trial in  patients formerly treated with advanced heptacellular carcinoma. In CELESTIAL, cabozantinib provided a statistically…
Read More...

Antibody discovery and optimization service provider, AvantGen claimed completion of its first cancer therapeutic antibody program in collaboration with Tanabe Research Laboratories USA…
Read More...

Cytovance Biologics a biopharmaceutical contract manufacturer of mammalian and microbial biologics proclaimed Edwin Miranda as Vice-President of Quality. Dr. Jesse McCool, Sr. Vice…
Read More...

Utilizing advanced analytics to offer workflow solutions and apps that advocate support solutions paving way for undisputed integration and analysis of in-vivo and in-vitro data, …
Read More...

Lustgarten Foundation alleges $22 million funding in 2017 as part of its mission to invest an unprecedented $40 million by the end of 2018. In a bid to advanced pancreatic Cancer…
Read More...

CGMP contract development and manufacturing organization (CDMO), Nitto Avecia Pharma Services appointed Raymond Kaczmarek as the president entrusting the P&L responsibility for the…
Read More...

The Pre-Filled Syringes East Coast Conference- April, 11-12, Sheraton Boston Hotel, Boston, MA, USA -your essential tool to learn, engage and network, and a must-attend meeting to…
Read More...

U.S Diagnostics confirms distribution of the INFINITY Blood Glucose Monitoring System across Western Africa. Located in New York, INFINITY Blood Glucose Monitoring System…
Read More...

Diplomat Pharmacy mets out CABOMETYX treatment for Renal cell carcinoma inflicted on patients as approved by the Food and Drug administration. Formerly approved as a second-line therapy…
Read More...